SUBSEQUENT EVENTS

6 Months Ended

Jun. 30, 2013

NOTE 11

SUBSEQUENT EVENTS

On June 28, 2013, Vystar Corporation entered into an LLC Ownership Interest Purchase Agreement with Michael Soo, M.D., the sole member of Kiron Clinical Sleep Lab, LLC (“Kiron”), a North Carolina limited liability company to purchase all outstanding membership and ownership interests of Kiron, and on July 1, 2013 completed such purchase. Dr. Soo has agreed to remain with Vystar/Kiron as Medical Director for the facilities and for other medical director opportunities as the Company expands the Kiron presence in North Carolina. The Company is currently undertaking an audit of Kiron’s financial results for the year ended 2011 and 2012 as well as the 6 months ended June 30, 2013. The Company expects to file an 8-K with respect to the final audit by September 11, 2013.

On August 28, 2013, the European Patent Office issued a Decision to Grant Vystar’s patent application under European Patent Number 1 902 089 titled “Decreasing Allergenicity of Natural Latex Rubber Prior to Vulcanization” greatly expanding the territory covered by the Company’s intellectual property portfolio. The mention of the grant is being published in the European Patent Bulletin 13/35 dated 28 August 2013.